U6 small nuclear RNA 503, pseudogene (RNU6-503P)

**RNU6-503P** is a **pseudogene** derived from U6 small nuclear RNA (snRNA), a highly conserved noncoding RNA that participates in mRNA splicing as part of the spliceosome[5]. Pseudogenes are generally considered “dead genomic elements” lacking protein-coding capacity or defined biological activity, although a minority (<5%) show signs of transcriptional or regulatory activity[2][6]. U6 snRNA is normally crucial to nuclear pre-mRNA splicing, but copies such as RNU6-503P are typically inactive remnants in the human genome and do not encode functional RNAs or proteins. **Key insights:** - **RNU6-503P** is a non-functional copy of a gene and is not a receptor or enzyme; it is not considered a therapeutic target[2][5]. - Occasional pseudogene transcription occurs, but RNU6-503P does not have documented biological function or disease association in available literature[2][5]. - U6 snRNA pseudogenes are common in vertebrate genomes, likely reflecting the evolutionary importance and prevalence of U6-related elements[5]. - Misclassification can occur in some gene annotation pipelines, but current evidence supports RNU6-503P as an authentic pseudogene rather than a functional gene or therapeutic target[4]. **Summary notes:** - **Not a receptor, enzyme, transporter, or recognized therapeutic target.** - **May be listed in genome annotation databases, but lacks function and clinical relevance.** - **Marked as “incorrect” as a therapeutic target due to its pseudogene status.**

Other names

RNU6-503PRNA, U6 small nuclear 503, pseudogene

None (no drugs target this pseudogene)